Sativa Investments shares ride wave of medicinal cannabis press

Sativa Investments, the UK's only medicinal cannabis investment vehicle, noted the recent rise in its share price on Friday, reporting that while it had made investments to date, it was unaware of any specific reason for the recent movement.

The Nex Exchange-listed company’s board noted the recent, significant increase in media and investor interest in the medical cannabis market, including a statement from the UK Home Secretary earlier this week highlighting the potential legalisation of cannabis for medicinal use in the UK.

"As the UK's only quoted medicinal cannabis company, the board believes Sativa is increasingly being viewed by the UK investment community as the de-facto UK investment vehicle for the sector, leading to the recent share price strength and enhanced demand for the company's shares," it said in its statement.

Sativa did attempt to draw investor attention to its admission document, noting that subscribers who participated at its initial public offering undertook not to dispose of any interest in ordinary shares for a period of 12 months following admission, which took place on 29 March.